Healthcare provider profile · identity verified

Jessie Wayne Castro

Family Practice · BELLWOOD, IL · NPI 1144614454

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	793	264
Amlodipine Besylate	Amlodipine Besylate	600	186
Metformin Hcl	Metformin Hcl	387	123
Lisinopril	Lisinopril	377	119
Losartan Potassium	Losartan Potassium	332	98
Gabapentin	Gabapentin	271	84
Albuterol Sulfate Hfa	Albuterol Sulfate	257	84
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	236	50
Hydrochlorothiazide	Hydrochlorothiazide	208	64
Metoprolol Succinate	Metoprolol Succinate	197	67
Tamsulosin Hcl	Tamsulosin Hcl	196	58
Rosuvastatin Calcium	Rosuvastatin Calcium	171	55
Omeprazole	Omeprazole	165	55
Levothyroxine Sodium	Levothyroxine Sodium	155	50
Carvedilol	Carvedilol	154	49
Tramadol Hcl	Tramadol Hcl	153	30
Metoprolol Tartrate	Metoprolol Tartrate	137	40
Furosemide	Furosemide	134	50
Fluticasone Propionate	Fluticasone Propionate	131	47
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	117	39
Naproxen	Naproxen	116	45
Baclofen	Baclofen	112	43
Pantoprazole Sodium	Pantoprazole Sodium	112	41
Duloxetine Hcl	Duloxetine Hcl	91	19
Alprazolam	Alprazolam	89	18
Enalapril Maleate	Enalapril Maleate	88	24
Simvastatin	Simvastatin	88	24
Prednisone	Prednisone	86	53
Ibuprofen	Ibuprofen	84	25
Glipizide	Glipizide	77	32
Nifedipine Er	Nifedipine	77	25
Sertraline Hcl	Sertraline Hcl	76	22
Pregabalin	Pregabalin	71	20
Triamcinolone Acetonide	Triamcinolone Acetonide	71	30
Alendronate Sodium	Alendronate Sodium	68	26
Famotidine	Famotidine	65	26
Hydralazine Hcl	Hydralazine Hcl	65	19
Clopidogrel	Clopidogrel Bisulfate	64	20
Eliquis	Apixaban	63	21
Trazodone Hcl	Trazodone Hcl	61	15
Januvia	Sitagliptin Phosphate	60	14
Ozempic	Semaglutide	60	18
Escitalopram Oxalate	Escitalopram Oxalate	57	14
Potassium Chloride	Potassium Chloride	57	23
Jardiance	Empagliflozin	56	22
Allopurinol	Allopurinol	54	19
Zolpidem Tartrate	Zolpidem Tartrate	54	15
Metformin Hcl Er	Metformin Hcl	53	22
Valsartan	Valsartan	51	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	26
Meclizine Hcl	Meclizine Hcl	49	21
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	49	23
Sildenafil Citrate	Sildenafil Citrate	49	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	41
Montelukast Sodium	Montelukast Sodium	45	12
Quetiapine Fumarate	Quetiapine Fumarate	45	12
Donepezil Hcl	Donepezil Hcl	44	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	17
Pravastatin Sodium	Pravastatin Sodium	42	14
Vitamin D2	Ergocalciferol (Vitamin D2)	42	12
Diclofenac Sodium	Diclofenac Sodium	41	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	15
Chlorthalidone	Chlorthalidone	38	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	13
Glipizide Er	Glipizide	35	suppressed
Azithromycin	Azithromycin	33	25
Celecoxib	Celecoxib	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Symbicort	Budesonide/Formoterol Fumarate	33	16
Latanoprost	Latanoprost	32	suppressed
Methocarbamol	Methocarbamol	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Lorazepam	Lorazepam	30	suppressed
Prazosin Hcl	Prazosin Hcl	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Ammonium Lactate	Ammonium Lactate	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Mupirocin	Mupirocin	27	15
Buspirone Hcl	Buspirone Hcl	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	19
Olanzapine	Olanzapine	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Torsemide	Torsemide	25	suppressed
Tradjenta	Linagliptin	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Meloxicam	Meloxicam	24	12
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Single Use Swab	Alcohol Antiseptic Pads	23	14
Xarelto	Rivaroxaban	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Ibu	Ibuprofen	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Telmisartan	Telmisartan	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	12
Finasteride	Finasteride	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	17
Alcohol Pads	Alcohol Antiseptic Pads	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Fluconazole	Fluconazole	15	12
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Betamethasone Valerate	Betamethasone Valerate	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Indomethacin	Indomethacin	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Ondansetron Odt	Ondansetron	13	11
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Nystatin	Nystatin	12	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Ec-Naproxen	Naproxen	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error